Efficacy and Safety of Ustekinumab as Maintenance Therapy in Ulcerative Colitis: Week 44 Results from UNIFIWJ Sandborn, Colleen Marano, Laurent Peyrin‐Biroulet et al.|Zeitschrift für Gastroenterologie|2019Cited by 7
Efficacy in Biologic Failure and Nonbiologic-Failure Populations in a Phase 3 Study of Ustekinumab in Moderate-Severe Ulcerative Colitis: UNIFIBE Sands, WJ Sandborn, Laurent Peyrin‐Biroulet et al.|Zeitschrift für Gastroenterologie|2019Cited by 2
Sustained Remission in Patients with Moderate to Severe Ulcerative Colitis: Results from the Phase 3 UNIFI Maintenance StudyGert Van Assche, Laurent Peyrin‐Biroulet, Ş. Targan et al.|Zeitschrift für Gastroenterologie|2019Cited by 0